Clinical Trials Arena April 4, 2025
The Safeguarded AI programme is said to transform the safety of AI by integrating scientific models with mathematical proofs.
The UK’s research and development (R&D) funding agency ARIA has granted funds to anti-clinical research organisation (CRO) Lindus Health for the development of a ‘reliable’ and safe artificial intelligence (AI) for trial design.
This initiative is part of ARIA’s Safeguarded AI programme.
The project, known as ‘Transforming clinical trial design using safe and reliable AI,’ will be a collaborative effort between Lindus Health and the research group of Nobuko Yoshida at the University of Oxford’s Department of Computer Science.
Lindus Health noted that current AI systems lack the necessary reliability in ‘high-stakes applications’ such as trial design, which could result...
Today's Sponsors
Today's Sponsor